As patients consider starting a family, they may want to have a better understanding of their genetic makeup, and whether they are at increased risk of passing along a genetic variant to their children. Genetic carrier screening is a crucial tool to help couples have a better understanding of risk and guide their family planning decisions.
As part of our commitment to providing clinically relevant, right-sized solutions, our QHerit® product portfolio has been designed to help you understand your patient’s genetic risks and support family planning discussions.
Our QHerit panels are ever-evolving, and we currently offer 5 screening panel options for up to 611 diseases to help you to select a medically appropriate panel based on your patient’s needs.
Our panels are designed with American College of Obstetricians and Gynecologists (ACOG) guidelines and American College of Medical Genetics and Genomics (ACMG) Practice Resources in mind.
We understand that you and your patients depend on these results for family planning and care. QHerit provides medically appropriate and clinically relevant insights that you and your patients need to help plan their futures.
We believe cost shouldn’t be a barrier to care. We are committed to keeping costs low so that more patients, regardless of their financial status, can access the screening they need.
a QHerit® 22, QHerit 112, QHerit 198, QHerit 445, and QHerit 611 are carrier screening tests, and they screen for variations in genes linked to certain health disorders that can be passed from parents to children. QHerit 22 screens for 24 genes, QHerit 112 screens for 113 genes, QHerit 198 screens for 199 genes, QHerit 445 screens for 446 genes, and QHerit 611 screens for 612 genes. For a full list of genes that each panel in the QHerit family screens, visit QHerit.com. If the results from any panel in the QHerit family suggest that a patient may be a carrier of a gene variation that can cause a health disorder in her offspring, it is recommended that her reproductive partner be offered genetic screening, and that genetic counseling be provided. Pregnancy management decisions should not be based on the results of these screening tests alone. As with any test, there may be false positives or false negatives. The positive predictive value of the screening test varies by genetic variation, and may be lower for rare conditions. Each panel in the QHerit family is a laboratory-developed test that has been developed and validated pursuant to the Clinical Laboratory Improvements Amendments of 1988 (CLIA) and, as such, it has not been reviewed by FDA.
b QHerit panels are screening tests. QHerit does not diagnose a disease or disorder.
c Panel components for males do not include specified X-linked diseases.
d Based on Quest Diagnostics full year 2023 claims analysis.
Test codes may vary by location. Please contact your local laboratory for more information.
While we offer a comprehensive testing menu, some patients may have an interest in screening for a specific disorder, such as cystic fibrosis. For these patients, Quest Diagnostics offers single-gene screening. Consultation available on genetic test selection and results interpretation 1.866.GENE.INFO (1.866.436.3463).
Please note that Quest offers a variety of single-gene and gene panel testing. For the genetic panels noted in this webpage, there may be single-gene tests or smaller panels that may be applicable for your patient. Refer to the Quest Diagnostics Test Directory for further information.
Listen to experts discuss taking a good sexual history, screening for specific patient populations, and implementation of STI screening in your practice.
Learn about our spinal muscular atrophy screening that can help provide greater insights and minimize uncertainty.
Genomic science specialists are available to help with test selection and results interpretation 1.866.GENE.INFO (1.866.436.3463)
Contact us to receive additional information on our lab tests, services, and coverage
Considering Pregnancy links
Your Privacy Choices
Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services. Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services.
Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.
